Why Centene Stock Is Trading Higher Today

Centene Corp (NYSE: CNC) has reported a Q1 FY23 adjusted EPS of $2.11, compared to $1.83 a year ago, slightly…
  • Centene Corp (NYSE: CNC) has reported a Q1 FY23 adjusted EPS of $2.11, compared to $1.83 a year ago, slightly beating the consensus of $2.10.
  • Sales increased 4.58% Y/Y to $38.89 billion, beating the consensus of $35.95 billion.
  • A health benefits ratio of 87% represents a decrease from 87.3% driven by continued disciplined Marketplace pricing and favorable Medicare performance.
  • Managed care membership reached 28.45 million, +8.45% Y/Y.
  • The cash flow provided by operations for the first quarter of 2023 was $4.3 billion.
  • FY 2023 Guidance: Centene has increased FY23 adjusted EPS guidance to at least $6.40 versus $6.25-$6.40 expected earlier versus a consensus of $6.36.
  • The company expects premium and service revenues of $135.2-$137.2 billion compared to $131.5-$133.5 billion expected earlier.
  • Centene forecasts FY23 revenues of $144.5-$146.5 billion compared to the consensus of $140.7 billion.
  • The company updated the 2024 Adjusted EPS target to over $6.60, reflecting an updated view of Medicaid redeterminations, Medicare bid strategy, and business investments.
  • Price Action: CNC shares are up 3.56% at $70.07 on the last check Tuesday.
Total
0
Shares
Related Posts
Read More

Benzinga’s Psychedelics Capital Conference Is Open For Business: Meet Our Renowned Keynote Speaker

This year is the second edition of what is rapidly becoming the place to be for those interested in or already involved in the psychedelics space: new deals get closed, money gets raised and knowledge is shared at this not-to-be-missed gathering for investors, key partners as well as the general public. 

NFLX